Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Patients With Metastatic Malignant Melanoma With Chemobiotherapy With Temozolomide, GM-CSF, IL2, and Interferon Alfa-2b Phase II Trial

NCT00014092 is registered in ClinicalTrials.gov with Saint Francis Hospital as lead sponsor.

NCT NCT00014092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00014092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Patients With Metastatic Malignant Melanoma With Chemobiotherapy With Temozolomide, GM-CSF, IL2, and Interferon Alfa-2b Phase II Trial
Lead sponsor
Saint Francis Hospital
Phase
Phase 2
Overall status
Completed
Start date
December 31, 1999
Completion date
December 31, 2003
Enrollment
Not reported
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma (skin)